These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19372701)

  • 21. Activity investigation of pinostrobin towards herpes simplex virus-1 as determined by atomic force microscopy.
    Wu N; Kong Y; Zu Y; Fu Y; Liu Z; Meng R; Liu X; Efferth T
    Phytomedicine; 2011 Jan; 18(2-3):110-8. PubMed ID: 20739162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
    Lebel A; Boivin G
    J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
    Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
    Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echinacea purpurea stimulates cellular immunity and anti-bacterial defence independently of the strain of mice.
    Bany J; Siwicki AK; Zdanowska D; Sokolnicka I; Skopińska-Rózewska E; Kowalczyk M
    Pol J Vet Sci; 2003; 6(3 Suppl):3-5. PubMed ID: 14509348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin control of herpes simplex virus lytic and latent infection.
    Knipe DM; Cliffe A
    Nat Rev Microbiol; 2008 Mar; 6(3):211-21. PubMed ID: 18264117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits.
    Myles ME; Azcuy AM; Nguyen NT; Reisch ER; Barker SA; Thompson HW; Hill JM
    J Pharmacol Exp Ther; 2004 Nov; 311(2):640-4. PubMed ID: 15254144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus type-1 latency inhibits dendritic growth in sympathetic neurons.
    Hamza MA; Higgins DM; Ruyechan WT
    Neurobiol Dis; 2006 Nov; 24(2):367-73. PubMed ID: 16952455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of herpes simplex virus reactivation by dipyridamole.
    Tenser RB; Gaydos A; Hay KA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3657-9. PubMed ID: 11709364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cycle of human herpes simplex virus infection: virus transport and immune control.
    Cunningham AL; Diefenbach RJ; Miranda-Saksena M; Bosnjak L; Kim M; Jones C; Douglas MW
    J Infect Dis; 2006 Sep; 194 Suppl 1():S11-8. PubMed ID: 16921466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiherpetic activities of sulfated polysaccharides from green algae.
    Lee JB; Hayashi K; Maeda M; Hayashi T
    Planta Med; 2004 Sep; 70(9):813-7. PubMed ID: 15386190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB/c mice.
    Jamali A; Mahdavi M; Shahabi S; Hassan ZM; Sabahi F; Javan M; Farsani MJ; Parsania M; Bamdad T
    Microb Pathog; 2007; 43(5-6):217-23. PubMed ID: 17669616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replication.
    Halford WP; Halford KJ; Pierce AT
    J Theor Biol; 2005 Jun; 234(3):439-54. PubMed ID: 15784277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.
    Pires de Mello CP; Bloom DC; Paixão IC
    Antivir Ther; 2016; 21(4):277-86. PubMed ID: 26726828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Situational antiviral drug prophylaxis for HSV type 1 recurrences.
    Hull C; Spruance S
    Herpes; 2007 Sep; 14(2):37-40. PubMed ID: 17939901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of latent bovine herpesvirus 2 DNA in tissues of experimentally infected sheep.
    Torres FD; Almeida SR; Silva MS; Weiblen R; Flores EF
    Res Vet Sci; 2009 Aug; 87(1):161-6. PubMed ID: 19157471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late relapse of herpes simplex virus encephalitis in a child due to reactivation of latent virus: clinicopathological report and review.
    Spiegel R; Miron D; Yodko H; Lumelsky D; Habib A; Horovitz Y
    J Child Neurol; 2008 Mar; 23(3):344-8. PubMed ID: 18230840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiviral effect of Folium Isatidis on herpes simplex virus type I].
    Fang JG; Hu Y; Tang J; Wang WQ; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(17):1343-6. PubMed ID: 16323544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tranylcypromine reduces herpes simplex virus 1 infection in mice.
    Yao HW; Lin PH; Shen FH; Perng GC; Tung YY; Hsu SM; Chen SH
    Antimicrob Agents Chemother; 2014 May; 58(5):2807-15. PubMed ID: 24590478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can HSV latency be conquered by current antiviral therapies?
    Simmons A; Field HJ
    Sex Transm Infect; 1998 Feb; 74(1):1-2. PubMed ID: 9634293
    [No Abstract]   [Full Text] [Related]  

  • 40. [A kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccination].
    Arefian E; Bamdad T; Soleimanjahi H; Akhood MR; Parsania M; Ghaemi A
    Mol Biol (Mosk); 2009; 43(3):422-8. PubMed ID: 19548528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.